Apr 23 2023
The marijuana compound cannabidiol (CBD) “inhibits colorectal cancer progression” and “prevents tumor progression”, according to a new study published by the Journal of Pharmaceutical Analysis. As noted by the study, colorectal tumors often create an immunosuppressive microenvironment that prevents them from responding to immunotherapy. This study “aimed to elucidate the specific anticancer mechanism of CBD …
Mar 30 2023
A sublingual spray that contains both CBD and THC “could be a new therapeutic agent for lipid and glycemic control in diabetic patients”, according to a double-blind, placebo-controlled clinical trial published by the Iranian Journal of Pharmaceutical Research, and epublished by the U.S. National Library of Medicine. Conducted by researchers at Shahid Beheshti University of …
Mar 25 2023
The cannabis compound cannabidiol (CBD) “acts as neuroprotector in dopaminergic neurons, reducing neurotoxicity and α-syn accumulation highlighting its potential in the treatment of PD”, according to a new study. The study is being published in the recent issue of the journal Neurochemical Research, and it was epublished online ahead of print by the National Library …
Mar 22 2023
Cannabidiol (CBD) was efficient in preventing chemotherapy-induced neuropathic pain in a new study published by the Journal of Pharmacy and Pharmacology. The study “aimed to investigate the effect of cannabidiol (CBD) on type 4 Toll-like receptors (TLR4), glial cells and pro-inflammatory cytokines during the neuropathic pain induced by the chemotherapy agent paclitaxel (PTX), as well …
Mar 22 2023
The marijuana compound cannabidiol “may help manage patients with Lennox-Gastaut Syndrome regarding seizure control and improve other aspects of the clinical spectrum of the disease”, according to new research. The research was published in the recent issue of the journal Epileptic Disorders. It was conducted by researchers at the University of Rome and the University …
Dec 22 2022
A study published in the most recent issue of the journal Advances in Skin & Wound Care has found that topical CBD “may be a valuable tool to treat pain related to digital ulcers in patients with systemic sclerosis.” A digital ulcer is a break in the skin of a finger or toe, which can …
Dec 21 2022
A long-term study of those with treatment-resistant epilepsy has found that the cannabis compound cannabidiol (CBD) is directly associated with a reduction in seizures over a 192-week period. The study, published by the journal Epilepsia, was conducted by researchers affiliated with the University of Alabama, NYU Langone’s Comprehensive Epilepsy Center, Loma Linda University Children’s Hospital, …
Nov 28 2022
Cannabidiol (CBD) has “direct antineoplastic [cancer treating] effects on lung cancer cells”, according to a new study being published in the upcoming issue of the Iranian Biomedical Journal. The study was epublished ahead of print on the website for the U.S. National Institute of Health. “Lung cancer remains a major factor contributing to morbidity and …
Nov 25 2022
A new study has found that CBD reduces seizures in patients with Dravet syndrome (SD), Lennox-Gataut syndrome (LGS), or tuberous sclerosis complex (TSC), who are resistant to common medications. Published by the journal Revista da Associação Médica Brasileira and epublished by the National Library of Medicine, the study was conducted by researchers at Medicina Baseada …
Nov 18 2022
On Wednesday the U.S. Senate passed the Medical Marijuana and Cannabidiol Research Expansion Act, making it the first standalone piece of marijuana legislation to ever reach the president’s desk. Now the White House says President Biden will soon sign it into law. H.R. 8454 passed the Senate on Wednesday and passed the House of Representatives …
